Search Results

PURPOSE: To evaluate the radiation enhancement by a combination of CPT-11 and etoposide, with in vitro ionizing radiation. MATERIALS AND METHODS: H460 human lung carcinoma cells were plated, and treated with 4.5 microM CPT-11 for 4 hr, then irradiated with various doses of radiation, and treated with 1microM etoposide for 1.5 hr. The survival and sublethal damage recovery (SLDR) were determined by a clonogenic assay. The analysis of apoptosis, due to the combined treatment with drugs and radiation, was performed using 7-AAD staining and flow cytometry. RESULTS: The survival experiments resulted in radiation dose enhancement ratios (DER) of 1.30, 1.39, and 1.65 for CPT-11, etoposide, and CPT-11 plus etoposide, respectively. The analysis of apoptosis, using 7-AAD staining and flow cytometry, indicated an synergistic effect. Inhibition of the SLDR was not observed with the CPT-11 plus etoposide. CONCLUSION: These data show that the combination of CPT-11 and etoposide is a more effective radiation enhancer in human lung cancer cells than either agent used individually in human lung cancer cells. This radiation enhancement is not caused by the inhibition of the SLDR, but other mechanisms may be involved in the combined treatment of CPT-11 and etoposide combined treatment.
Apoptosis ; Etoposide* ; Flow Cytometry ; Humans* ; Lung Neoplasms* ; Lung* ; Radiation, Ionizing

1.Treatment of advanced gastric cancer with 5-fluorouracil, etoposide and cisplatin(FEP).

2.Phase I clinical trial of simultaneous administration of intraperitoneal carboplatin, etoposide and cytosine arabinoside for refractory ovarian carcinoma.

3.Phase II trial of VP-16 plus cisplatin for advanced epithelial ovarian cancer.

4.FAM versus etoposide, adriamycin, and cisplatin:a random assignment trial in advanced gastric cancer.

5.Etoposide, adriamycin, cisplatin(EAP) combination chemotherapy for advanced gastric cancer.

6.Etoposide, adriamycin and cisplatin(EAP) chemotherapy in advanced gastric cancer.

7.Induction of apoptosis by etoposide treatment in colon cancer cell line SNU C2A.

8.Chemotherapy with mitoxantrone and etoposide in patients with highly refractory acute leukemia.

9.Alterating combination chemotherapy of cyclophosphamide, adriamycin, and vincristine(CAV) with etoposide and cisplatin(EP) in small cell lung cancer.

10.Radiation Enhancement by The Combined Use of CPT-11 and Etoposide in Human Lung Cancer Cells.

Display Mode

Output Records

File Type